13th edition

Format
HYBRID

December 3rd & 4th, 2024

IN-PERSON | LILLE, FR

December 11th& 12th 2024

ONLINE MEETINGS

Stand F10

2022 Edition

Paras Biopharmaceuticals Finland Oy

Finland

Company activities & offerings are categorized in 3 major areas:
1. Contract development & microbial biologics manufacturing (CDMO).
2. Development of Recombinant expression systems and process technologies for biologics and biosimilars.
3. Paras Biopharmaceuticals has developed and is offering Recombinant Bioprocess enzymes.

Scroll to Top
  • No products in the cart.